Shurin, M. R., & Umansky, V. (2022). Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy. The journal of clinical investigation, 132(9), . https://doi.org/10.1172/JCI159473
Chicago-Zitierstil (17. Ausg.)Shurin, Michael R., und Viktor Umansky. "Cross-talk Between HIF and PD-1/PD-L1 Pathways in Carcinogenesis and Therapy." The Journal of Clinical Investigation 132, no. 9 (2022). https://doi.org/10.1172/JCI159473.
MLA-Zitierstil (9. Ausg.)Shurin, Michael R., und Viktor Umansky. "Cross-talk Between HIF and PD-1/PD-L1 Pathways in Carcinogenesis and Therapy." The Journal of Clinical Investigation, vol. 132, no. 9, 2022, https://doi.org/10.1172/JCI159473.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.